Silk

• Composition: Natural protein fiber
• Structure: Braided
• Advantages: Excellent handling, superior knot security, cost-effective
• Disadvantages: Inflammatory response, bacterial adherence, gradual weakening
• Clinical uses: Oral surgery, temporary sutures requiring easy removal

Nylon (Polyamide)

• Structure: Monofilament or braided
• Advantages: High tensile strength, minimal tissue reaction
• Disadvantages: Difficult handling, poor knot security
• Clinical uses: Skin closure, situations requiring high strength

Polypropylene (Prolene)

• Structure: Monofilament
• Advantages: Chemically inert, minimal tissue reaction, maintains strength
• Disadvantages: Difficult handling, tendency to cut through tissues
• Clinical uses: Vascular surgery, situations requiring permanent support

• NOE fracture test: Bow string test
• Blow-out fracture types:
  • Pure: Orbital rim intact
  • Impure: Rim + facial bones involved
• LeFort fracture hemorrhage source: Fractured septum
• CSF rhinorrhea test: Beta-2 transferrin

Dental/Oral/Upper Respiratory Tract Procedures: Antibiotic Prophylaxis Guidelines

Antibiotic prophylaxis is crucial for patients at risk of infective endocarditis or other infections during dental, oral, or upper respiratory tract procedures. The following guidelines outline the standard and alternate regimens for antibiotic prophylaxis based on the patient's allergy status and ability to take oral medications.

I. Standard Regimen in Patients at Risk

1. For Patients Allergic to Penicillin/Ampicillin/Amoxicillin:

   • Erythromycin:
     • Dosage: Erythromycin ethyl-succinate 800 mg or erythromycin stearate 1.0 gm orally.
     • Timing: Administer 2 hours before the procedure.
     • Follow-up Dose: One-half of the original dose (400 mg or 500 mg) 6 hours after the initial administration.
   • Clindamycin:
     • Dosage: Clindamycin 300 mg orally.
     • Timing: Administer 1 hour before the procedure.
     • Follow-up Dose: 150 mg 6 hours after the initial dose.

2. For Non-Allergic Patients:

   • Amoxicillin:
     • Dosage: Amoxicillin 3.0 gm orally.
     • Timing: Administer 1 hour before the procedure.
     • Follow-up Dose: 1.5 gm 6 hours after the initial dose.

II. Alternate Prophylactic Regimens in Patients at Risk

1. For Patients Who Cannot Take Oral Medications:

   • For Penicillin/Amoxicillin Allergic Patients:
     • Clindamycin:
       • Dosage: Clindamycin 300 mg IV.
       • Timing: Administer 30 minutes before the procedure.
       • Follow-up Dose: 150 mg IV (or orally) 6 hours after the initial dose.
   • For Non-Allergic Patients:
     • Ampicillin:
       • Dosage: Ampicillin 2.0 gm IV or IM.
       • Timing: Administer 30 minutes before the procedure.
       • Follow-up Dose: Ampicillin 1.0 gm IV (or IM) or amoxicillin 1.5 gm orally 6 hours after the initial dose.

2. For High-Risk Patients Who Are Not Candidates for the Standard Regimen:

   • For Penicillin/Amoxicillin Allergic Patients:
     • Vancomycin:
       • Dosage: Vancomycin 1.0 gm IV.
       • Timing: Administer over 1 hour, starting 1 hour before the procedure.
       • Follow-up Dose: No repeat dose is necessary.
   • For Non-Allergic Patients:
     • Ampicillin and Gentamicin:
       • Dosage: Ampicillin 2.0 gm IV (or IM) plus gentamicin 1.5 mg/kg IV (or IM) (not to exceed 80 mg).
       • Timing: Administer 30 minutes before the procedure.
       • Follow-up Dose: Amoxicillin 1.5 gm orally 6 hours after the initial dose. Alternatively, the parenteral regimen may be repeated 8 hours after the initial dose.

Postoperative Airway Obstruction

Causes

• Hematoma: Expanding neck hematoma
• Edema: Laryngeal or facial swelling
• Vocal cord paralysis: Recurrent laryngeal nerve injury
• Foreign body: Gauze, blood clots

Management

• Assessment: Rapid evaluation of obstruction level
• Position: Sitting up if conscious, stable
• Suction: Remove blood/debris if visible
• Medications: Steroids for edema, epinephrine for anaphylaxis
• Definitive: Secure airway if conservative measures fail

Anaphylaxis

Recognition

• Rapid onset: Minutes after exposure
• Skin: Urticaria, angioedema
• Respiratory: Bronchospasm, laryngeal edema
• Cardiovascular: Hypotension, tachycardia

Treatment

• Epinephrine: 0.3-0.5mg IM (1:1000)
• Airway: May need emergency surgical airway
• Fluids: Aggressive IV resuscitation
• Antihistamines: H1 and H2 blockers
• Steroids: Prevent biphasic reaction

Laryngospasm

Triggers

• Stimulation: Light anesthesia, secretions
• Irritants: Blood, gastric contents
• Medications: Propofol, succinylcholine

Treatment

• Positive pressure: Gentle bag-mask ventilation
• Larson's maneuver: Pressure at laryngospasm notch
• Succinylcholine: 0.25-0.5 mg/kg if severe
• Intubation: May be necessary if persistent

Management of Septic Shock

Septic shock is a life-threatening condition characterized by severe infection leading to systemic inflammation, vasodilation, and impaired tissue perfusion. Effective management is crucial to improve outcomes and reduce mortality. The management of septic shock should be based on several key principles:

Key Principles of Management

1. Early and Effective Volume Replacement:

   • Fluid Resuscitation: Initiate aggressive fluid resuscitation with crystalloids (e.g., normal saline or lactated Ringer's solution) to restore intravascular volume and improve circulation.
   • Goal: Aim for a rapid infusion of 30 mL/kg of crystalloid fluids within the first 3 hours of recognition of septic shock.

2. Restoration of Tissue Perfusion:

   • Monitoring: Continuous monitoring of vital signs, urine output, and laboratory parameters to assess the effectiveness of resuscitation.
   • Target Blood Pressure: In most patients, a systolic blood pressure of 90 to 100 mm Hg or a mean arterial pressure (MAP) of 70 to 75 mm Hg is considered acceptable.

3. Adequate Oxygen Supply to Cells:

   • Oxygen Delivery: Ensure adequate oxygen delivery to tissues by maintaining hemoglobin saturation (SaO2) above 95% and arterial oxygen tension (PaO2) above 60 mm Hg.
   • Hematocrit: Maintain hematocrit levels above 30% to ensure sufficient oxygen-carrying capacity.

4. Control of Infection:

   • Antibiotic Therapy: Administer broad-spectrum antibiotics as soon as possible, ideally within the first hour of recognizing septic shock. Adjust based on culture results and sensitivity.
   • Source Control: Identify and control the source of infection (e.g., drainage of abscesses, removal of infected devices).

Pharmacological Management

1. Vasopressor Therapy:

   • Indication: If hypotension persists despite adequate fluid resuscitation, vasopressors are required to increase arterial pressure.
   • First-Line Agents:
     • Dopamine: Often the first choice due to its ability to maintain organ blood flow, particularly to the kidneys and mesenteric circulation. Typical dosing is 20 to 25 micrograms/kg/min.
     • Noradrenaline (Norepinephrine): Should be added if hypotension persists despite dopamine administration. It is the preferred vasopressor for septic shock due to its potent vasoconstrictive properties.

2. Cardiac Output and Myocardial Function:

   • Dobutamine: If myocardial depression is suspected (e.g., low cardiac output despite adequate blood pressure), dobutamine can be added to improve cardiac output without significantly increasing arterial pressure. This helps restore oxygen delivery to tissues.
   • Monitoring: Continuous monitoring of cardiac output and systemic vascular resistance is essential to assess the effectiveness of treatment.

Additional Considerations

• Supportive Care: Provide supportive care, including mechanical ventilation if necessary, and monitor for complications such as acute respiratory distress syndrome (ARDS) or acute kidney injury (AKI).
• Nutritional Support: Early enteral nutrition should be initiated as soon as feasible to support metabolic needs and improve outcomes.
• Reassessment: Regularly reassess the patient's hemodynamic status and adjust fluid and medication therapy accordingly.